Abstract: Pseudorabies virus (PRV), known as porcine herpesvirus type I, belongs to the α-herpesvirus subfamily of the herpesviridae family. Its virions are oval or round, with a genome of approximately 143 000 bp and a high guanine-cytosine (GC) content of 73% (Pomeranz et al., 2005). While swine are the natural host and the virus has caused significant economic loss to the pig industry, PRV can infect other mammals, causing acute infectious diseases characterized by neurological symptoms (He et al., 2019; Cheng et al., 2020). Young pigs are more susceptible to PRV and the infection in piglets is nearly 100% fatal, whereas adult pigs exhibit reproductive disorders such as abortion, stillbirths, and reduced fertility, ultimately decreasing farm productivity (Zuckermann, 2000). Due to its global impact, PRV is classified as a Class B infectious disease by the World Organization for Animal Health (WOAH).

基于gN基因的伪狂犬病病毒TaqMan qPCR分型方法的建立及应用

[1]AnTQ, PengJM, TianZJ, et al., 2013. Pseudorabies virus variant in Bartha-K61‒vaccinated pigs, China, 2012. Emerg Infect Dis, 19(11):1749-1755.

[2]ChengZL, KongZJ, LiuP, et al., 2020. Natural infection of a variant pseudorabies virus leads to bovine death in China. Transbound Emerg Dis, 67(2):518-522.

[3]DelvaJL, NauwynckHJ, MettenleiterTC, et al., 2020. The attenuated pseudorabies virus vaccine strain Bartha K61: a brief review on the knowledge gathered during 60 years of research. Pathogens, 9(11):897.

[4]DingSX, ShenTR, FengZX, et al., 2024. Development of a highly sensitive TaqMan method based on multi-probe strategy: its application in ASFV detection. Biol Methods Protoc, 9(1):bpae011.

[5]HeWT, AuclertLZ, ZhaiXF, et al., 2019. Interspecies transmission, genetic diversity, and evolutionary dynamics of pseudorabies virus. J Infect Dis, 219(11):1705-1715.

[6]JinYL, YinD, XingG, et al., 2022. The inactivated gE/TK gene-deleted vaccine against pseudorabies virus type II confers effective protection in mice and pigs. Front Microbiol, 13:943707.

[7]MorenkovOS, SobkoYA, PanchenkoOA, 1997. Glycoprotein gE blocking ELISAs to differentiate between Aujeszky’s disease-vaccinated and infected animals. J Virol Methods, 65(1):83-94.

[8]PomeranzLE, ReynoldsAE, HengartnerCJ, 2005. Molecular biology of pseudorabies virus: impact on neurovirology and veterinary medicine. Microbiol Mol Biol Rev, 69(3):462-500.

[9]SongCL, GaoLB, BaiWB, et al., 2017. Molecular epidemiology of pseudorabies virus in Yunnan and the sequence analysis of its gD gene. Virus Genes, 53(3):392-399.

[10]State Administration for Market Regulation, Standardization Administration of China, 2018. Diagnostic Method for Pseudorabies, GB/T 18641-2018. Standards Press of China, Beijing, China.

[11]TanL, YaoJ, YangYD, et al., 2021. Current status and challenge of pseudorabies virus infection in China. Virol Sin, 36(4):588-607.

[12]TuF, ZhangYN, XuSK, et al., 2022. Detection of pseudorabies virus with a real-time recombinase-aided amplification assay. Transbound Emerg Dis, 69(4):2266-2274.

[13]WuXM, ChenRJ, ChenQY, et al., 2023. Establishment of an indirect ELISA method for antibody detection of porcine pseudorabies by recombinant gB, gC, and gD proteins. J Med Virol, 95(1):e28228.

[14]ZhaiXF, ZhaoW, LiKM, et al., 2019. Genome characteristics and evolution of pseudorabies virus strains in Eastern China from 2017 to 2019. Virol Sin, 34(6):601-609.

[15]ZhengHH, FuPF, ChenHY, et al., 2022. Pseudorabies virus: from pathogenesis to prevention strategies. Viruses, 14(8):1638.

[16]ZuckermannFA, 2000. Aujeszky’s disease virus: opportunities and challenges. Vet Res, 31(1):121-131.

Similar articles